Based on a parenteral route of exposure would provide 100% bio-availability the EU regulators believe they are the greatest risk. All the data we have collected shows this to be an erroneous view. This case will be illustrated by Data and an explanation made as to why OSD is is the greatest Risk.
The majority of CMO' we interact with do not understand what is happening and why they need to plan for the new requirements even if they do not supply the EU.
Based on a parenteral route of exposure would provide 100% bio-availability the EU regulators believe they are the greatest risk. All the data we have collected shows this to be an erroneous view. This case will be illustrated by Data and an explanation made as to why OSD is is the greatest Risk.
The majority of CMO' we interact with do not understand what is happening and why they need to plan for the new requirements even if they do not supply the EU.
Based on a parenteral route of exposure would provide 100% bio-availability the EU regulators believe they are the greatest risk. All the data we have collected shows this to be an erroneous view. This case will be illustrated by Data and an explanation made as to why OSD is is the greatest Risk.
The majority of CMO' we interact with do not understand what is happening and why they need to plan for the new requirements even if they do not supply the EU. will be held in Fremont,United States on date 2015-04-27
Deadline for abstracts/proposals : 26th April 2015